Skip to main content

Paying for Treatment

What's new

Ascensia Diabetes Care just launched a new Patient Assistance Program, which is now available in the US. The program aims to reduce out-of-pocket expenses for those who are starting or already using Senseonics’ Eversense 90-day implantable continuous glucose monitoring system. Continue Reading »

Medicare has updated its policy to now accept the inhaled insulin Afrezza, as well as injected insulin options to count towards the multiple daily administrations of insulin requirement for glucose monitoring systems coverage. Continue Reading »

Have you or someone you know had trouble affording diabetes care during COVID-19? During the pandemic, healthcare companies have created programs to help people get diabetes medications and devices. More than a year into COVID, which access programs exist, and how long we can expect them to stay in place? Continue Reading »